Gavin Maggs, chief executive of Children with Cancer UK, added: “The projects we’re funding are not just advancing scientific knowledge, they have the potential to fundamentally change how these cancers are diagnosed and treated, offering children safer and more effective options than ever before.
Trending
- Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial
- MMSDH facilitates ACSL4 propionylation to counteract ferroptosis upon hypoxia and impairs PDAC chemotherapy efficacy
- Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma
- ATR inhibition induces NF-κB-dependent immunogenicity in Merkel cell carcinoma independent of cGAS-STING
- Debating CAR T-Cell Therapy Vs Bispecifics at First Relapse in Myeloma
- A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1α secretion
- Scientists find a way to break pancreatic cancer’s protective shield
- Perioperative Durvalumab Combo Boosts Survival in Resectable Gastric Cancer
Sunday, September 13
